About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
GMED - Globus Medical| Previous Close | $52.74 | Open | $53.56 |
| Volume | 1.15M | Market Cap | 3.918B |
| Yield | Last Dividend |
| Globus Medical (GMED) Misses on Q1 Earni... | 05/08/20 |
| Globus Medical (GMED) witnesses around $20 million of COVID-19 related adverse impact on its Q1 sales. | |
| Globus Medical (GMED) Lags Q1 Earnings a... | 05/07/20 |
| Globus Medical (GMED) delivered earnings and revenue surprises of -27.50% and -4.65%, respectively, for the quarter ended March 2020. Do the numbers h... | |
| Why Is Globus Medical (GMED) Down 28.9% ... | 03/21/20 |
| Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| BTIG Buys Into Globus Medical's Longer-T... | 03/18/20 |
| Globus Medical Inc???s (NYSE: GMED ) shares have declined around 33% from their year-end 2019 high, and the company has a strong balance sheet that ca... | |
| Global Spinal Implants Market 2020-2024 ... | 02/25/20 |
| LONDON--(BUSINESS WIRE)-- #GlobalSpinalImplantsMarket--The global spinal implants market is poised to grow by USD 2.75 billion during 2020-2024 | |
| Stock Alert: Globus Medical (GMED) | 02/12/20 |
| Globus Medical Inc. (GMED) is all set to announce its financial results for the fourth quarter and full-year ended December 31, 2019, after the market... | |
| Globus Medical Gains From International ... | 01/16/20 |
| Globus Medical (GMED) delivers solid spine sales globally. Enabling Technologies too rides high on the rising uptake of ExcelsiusGPS platform. | |
| The Daily Biotech Pulse: Axovant Surges ... | 12/20/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs D... | |
| Here's Why You Should Hold on to Globus ... | 12/19/19 |
| Investors continue to be optimistic about Globus Medical (GMED) on its stellar segmental performance. | |
| The Daily Biotech Pulse: Positive Adcom ... | 12/18/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) ... | |
| The Daily Biotech Pulse: Second Time's T... | 12/13/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: ASH Meeting Wra... | 12/10/19 |
| The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 9.) Acce... | |
| Why Is Globus Medical (GMED) Up 3.9% Sin... | 12/06/19 |
| Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| The Daily Biotech Pulse: Tonix Says No S... | 11/27/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 26) ... | |
| The Daily Biotech Pulse: ChemoCentryx Tr... | 11/26/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.... | |
| The Daily Biotech Pulse: Endo's Cellulit... | 11/20/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) ... | |
| Globus Medical's U.S. Spine Arm Grows, P... | 11/12/19 |
| Globus Medical (GMED) is on course to commercially market ExcelsiusGPS platform and launch its spine deformity solution in early fourth quarter. | |
| Globus Medical (NYSE:GMED) Receives Hold... | 11/12/19 |
| BTIG Research restated their hold rating on shares of Globus Medical (NYSE:GMED) in a research note released on Thursday morning, AnalystRatings.com r... | |
| Globus Medical (GMED) Q3 Earnings Meet M... | 11/07/19 |
| Globus Medical (GMED) reports robust top-line numbers for the third quarter on segmental strength. | |
| Globus Medical (GMED) Earnings Expected ... | 10/30/19 |
| Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared... | |
| Did Hedge Funds Drop The Ball On Globus ... | 10/24/19 |
| Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 d... | |
| Here's Why You Should Retain Globus Medi... | 09/18/19 |
| Investor confidence continues to be high in Globus Medical (GMED), thanks to solid prospects. | |
| Globus Medical (GMED) Up 10.1% Since Las... | 08/31/19 |
| Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Globus Medical (GMED) Q2 Earnings In Lin... | 08/02/19 |
| Globus Medical's (GMED) spine business gains traction from solid worldwide growth in the second quarter. | |
| Globus Medical (GMED) Q2 Earnings Match ... | 08/01/19 |
| Globus Medical (GMED) delivered earnings and revenue surprises of 0.00% and 5.77%, respectively, for the quarter ended June 2019. Do the numbers hold ... | |
| Earnings Preview: Globus Medical (GMED) ... | 07/25/19 |
| Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared... | |
| Globus Medical Reveals Positive Study Re... | 05/24/19 |
| Results of the study of ExcelsiusGPS reached a milestone for Globus Medical (GMED) in the field of robotics-assisted, minimally invasive pedicle screw... | |
| Globus Medical (GMED) Q1 Earnings Miss, ... | 05/05/19 |
| Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly ... | |
| Globus Medical (GMED) Q1 Earnings Miss M... | 05/03/19 |
| Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly ... | |
| Globus Medical, Inc. (GMED) CEO Dave Dem... | 05/02/19 |
| Globus Medical, Inc. (NYSE:GMED) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants Brian Kearns - Senior Vice President-Bus... | |
| Strong Buy rating | 05/08/20 |
| SVB Leerink maintains Outperform rating and lowers Price Target from $63.00 to $56.00 | |
| Buy rating | 05/08/20 |
| Needham maintains Buy rating and lowers Price Target from $63.00 to $60.00 | |
| Hold rating | 05/08/20 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $48.00 to $52.00 | |
| Strong Buy rating | 05/08/20 |
| Credit Suisse maintains Outperform rating and raises Price Target from $56.00 to $57.00 | |
| Buy rating | 05/08/20 |
| UBS maintains Buy rating and lowers Price Target from $67.00 to $61.00 | |
| Strong Buy rating | 04/06/20 |
| Wells Fargo maintains Overweight rating and lowers Price Target from $63.00 to $50.00 | |
| Hold rating | 03/27/20 |
| Morgan Stanley maintains Equal-Weight rating and lowers Price Target from $60.00 to $48.00 | |
| Buy rating | 03/18/20 |
| BTIG upgrades from Neutral to Buy rating and announces Price Target of $46.00 | |
| Date | 2020-05-07 (AMC) | Est. (EPS/Rev.) | $0.38/ 194.5M |
| Actual (EPS/Rev.) | $0.29/ $190.58 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| TopFlight Trades - Premium (Options) | Eric Cunningham | 51.00 % | Follow |
| TopFlight Trades - Premium (Stocks) | Eric Cunningham | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
